FDA Approves ROSUVASTATIN CALCIUM — PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS
Puracap Laboratories LLC doing business as Blu Pharmaceuticals has secured FDA approval for the oral rosuvastatin calcium generic, targeting the high-volume statin market; this approval is expected to increase competition and drive pricing pressure on branded therapies.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed